New shot vs. old drug: battle for better skin cancer control in vulnerable patients

NCT ID NCT07042295

Summary

This study is for people with a weakened immune system who have advanced skin cancer (squamous cell carcinoma) that has returned or spread. It compares a newer treatment given as an injection (amivantamab) against a standard treatment given by IV (cetuximab). The goal is to see which one better controls the cancer's growth and is safer for this specific group of patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC SKIN SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Carle BroMenn Medical Center

    RECRUITING

    Normal, Illinois, 61761, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Carle Cancer Center

    RECRUITING

    Urbana, Illinois, 61801, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Carle Cancer Institute Normal

    RECRUITING

    Normal, Illinois, 61761, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Carle Physician Group-Effingham

    RECRUITING

    Effingham, Illinois, 62401, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Carle Physician Group-Mattoon/Charleston

    RECRUITING

    Mattoon, Illinois, 61938, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Carle at The Riverfront

    RECRUITING

    Danville, Illinois, 61832, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UC San Diego Moores Cancer Center

    RECRUITING

    La Jolla, California, 92093, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Michigan Rogel Cancer Center

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yale University

    RECRUITING

    New Haven, Connecticut, 06520, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.